Case series of ultrasound-guided platelet-rich plasma injections for sacroiliac joint dysfunction

Abstract

BACKGROUND:

Two-thirds of adults worldwide will experience low back pain at some point in their life. In the following case series, we present four patients with sacroiliac (SI) joint instability and severe chronic low back pain, which was refractory to other treatment modalities.

OBJECTIVE:

We investigated the efficacy of platelet-rich plasma(PRP) injections, a novel orthobiologic therapy, for reducing SI joint pain, improving quality of life, and maintaining a clinical effect.

METHODS:

Short-form McGill Pain Questionnaire (SFM), Numeric Rating Scale (NRS), and Oswestry Low Back Pain and Disability Index were used for evaluation of treatment at pretreatment, 12-months and 48-months after treatment.

RESULTS:

At follow-up 12-months post-treatment, pooled data from all patients reported a marked improvement in joint stability, a statistically significant reduction in pain, and improvement in quality of life. The clinical benefits of PRP were still significant at 4-years post-treatment.

CONCLUSIONS:

Platelet-rich plasma therapy exhibits clinical usefulness in both pain reduction and for functional improvement in patients with chronic SI joint pain. The improvement in joint stability and low back pain was maintained at 1- and 4-years post-treatment.

Keywords

Musculoskeletal and joint disorders drugs and medicines orthopaedics back pain occupational and environmental medicine Ehlers-Danlos syndrome ligament laxity sports and exercise medicine fibromyalgia neuropathic pain motor vehicle accident

References

Hoy

, Bain

, Williams

, et al. A systematic review of the global prevalence of low back pain. Arthritis and rheumatism. 2012; 64: 2028-37. doi: 10.1002/art.34347.

Maetzel

, Li

. The economic burden of low back pain: A review of studies published between 1996 and 2001. Best Practice & Research Clinical Rheumatology. 2002; 16: 23-30.

Deyo

, Weinstein

. Low back pain. The New England Journal of Medicine. 2001; 344: 363-70.

Goldthwait

, Osgood

. A consideration of the pelvic articulations from an anotomical, pathological and clinical standpoint. The Boston Medical and Surgical Journal. 1905; 152: 634-8. doi: 10.1056/NEJM190506011522204.

Bernard

, Kirkaldy-Willis

. Recognizing specific characteristics of nonspecific low back pain. Clinical Orthopaedics and Related Research. 1987; 266-80.

Lee

, Lee

S-H

, Song

. Clinical effectiveness of botulinum toxin A compared to a mixture of steroid and local anesthetics as a treatment for sacroiliac joint pain. Pain medicine (Malden, Mass). 2010; 11: 692-700. doi: 10.1111/j.1526-4637.2010.00838.

White

, Arnold

, Norvell

, et al. Pharmacologic management of chronic low back pain: Synthesis of the evidence. Spine. 2011; 36: S131-43. doi: 10.1097/BRS.0b013e31822f178f.

Geisler

. Stabilization of the sacroiliac joint with the SI-Bone surgical technique. Neurosurgical focus. 2013; 35 Suppl: Video8. doi: 10.3171/2013.V2.FOCUS13195.

Cohen

. Sacroiliac joint pain: A comprehensive review of anatomy, diagnosis, and treatment. Anesthesia and Analgesia. 2005; 101: 1440-53.

10.

Hansen

, McKenzie-Brown

, Cohen

, et al. Sacroiliac joint interventions: A systematic review. Pain physician. 2007; 10: 165-84.

11.

Marx

. Platelet-rich plasma: evidence to support its use. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons. 2004; 62: 489-96.

12.

Roberts

, Sporn

, Assoian

, et al. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro . Proceedings of the National Academy of Sciences of the United States of America. 1986; 83: 4167-71.

13.

Heldin

, Westermark

. Mechanism of action and in vivo role of platelet-derived growth factor. Physiological Reviews. 1999; 79: 1283-316.

14.

Froech

, Schmid

, Schwander

, et al. Actions of insulin-like growth factors. Annual Review of Physiology. 1985; 47: 443-67.

15.

Ferrara

, Gerber

H-P

, LeCouter

. The biology of VEGF and its receptors. Nature Medicine. 2003; 9: 669-76.

16.

Cuevas

, Burgos

, Baird

. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo . Biochemical and Biophysical Research Communications. 1988; 156: 611-8.

17.

Chua

, Geiman

, Keller

, et al. Induction of collagenase secretion in human fibroblast cultures by growth promoting factors. The Journal of Biological Chemistry. 1985; 260: 5213-6.

18.

Van der Zee

, Jansen

, Hoeben

, et al. EGF and IL-1 alpha modulate the release of collagenase, gelatinase and TIMP-1 as well as the release of calcium by rabbit calvarial bone explants. Journal of Periodontal Research. 1998; 33: 65-72.

19.

De Mos

, van der Windt

, Jahr

, et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. The American Journal of Sports Medicine. 2008; 36: 1171-8. doi: 10.1177/0363546508314430.

20.

Schnabel

, Mohammed

, Miller

, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. Journal of Orthopaedic Research. 2007; 25: 230-40.

21.

Lyras

, Kazakos

, Agrogiannis

, et al. Experimental study of tendon healing early phase: is IGF-1 expression influenced by platelet rich plasma gel? Orthopaedics & Traumatology, Surgery & Research. 2010; 96: 381-7. doi: 10.1016/j.otsr.2010.03.010.

22.

Aspenberg

, Virchenko

. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthopaedica Scandinavica. 2004; 75: 93-9.

23.

Lyras

, Kazakos

, Verettas

, et al. The effect of platelet-rich plasma gel in the early phase of patellar tendon healing. Archives of Orthopaedic and Trauma Surgery. 2009; 129: 1577-82. doi: 10.1007/s00402-009-0935-4.

24.

Laudy

, Bakker

, Rekers

, Moen

. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: A systemic review and meta-analysis. British Journal of Sports Medicine. 2014 Nov 21. doi: 10.1136/bjsports-2014-094036.

25.

Raeissadat

, Rayegani

, Hassanabadi

, Fathi

, et al. Knee osteoarthritis injection choices: platelet-rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2015; 8: 1-3. doi: 10.4137/CMAMD.S17894.eCollection2015.

26.

Goldring

, Goldring

. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clinical Orthopaedics and Related Research. 2004, S27-36.

27.

Hammond

, Hinton

, Curl

, et al. Use of autologous platelet-rich plasma to treat muscle strain injuries. The American Journal of Sports Medicine. 2009; 37: 1135-42. doi: 10.1177/0363546508330974.

28.

Mishra

, Pavelko

. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. The American Journal of Sports Medicine. 2006; 34: 1774-8.

29.

Peerbooms

, Sluimer

, Bruijn

, et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized control trial: platelet rich plasma versus corticosteroid injection with a 1-year follow-up. The American Journal of Sports Medicine. 2010; 38: 255-62. doi: 10.1177/0363546509355445.

30.

Randelli

, Arrigoni

, Cabitza

, et al. Autologous platelet rich plasma for arthroscopic rotator cuff repair. A pilot study. Disability and Rehabilitation. 2008; 30: 1584-9. doi: 10.1080/09638280801906081.

31.

Sanchez

, Anitua

, Azofra

, et al. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. The American Journal of Sports Medicine. 2007; 35: 245-51.

32.

Kon

, Mandelbaum

, Buda

, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis. Arthroscopy. 2011; 27: 1490-501. doi: 10.1016/j.arthro.2011.05.011.

33.

Smith

. Intra-articular Autologous Conditioned Plasma Injections provide safe and efficacious treatment for Knee OA: An FDA-sanctioned randomized double-blind placebo-controlled clinical trial. American Journal of Sports Medicine. 2016; doi: 10.1177/0363546515624678.

34.

Filardo

, Kon

, Di Martino

, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: Study design and preliminary results of a randomized controlled trial. BMC Musculoskeletal Disorders. 2012; 13: 229. doi: 10.1186/1471-2474-13-229.

35.

Schepull

, Kvist

, Norrman

, et al. Autologous platelets have no effect on the healing of human Achilles tendon ruptures: A randomized single-blind study. The American Journal of Sports Medicine. 2011; 39: 38-47. doi: 10.1177/0363546510383515.

36.

Rupert

, Lee

, Manchikanti

, et al. Evaluation of sacroiliac joint interventions: a systemic appraisal of the literature. Pain Physician. 2009; 12: 399-418.

37.

Krebs

, Carey

, Weinberger

. Accuracy of the pain numeric rating scale as a screening test in primary care. Journal of General Internal Medicine. 2007; 22: 1453-8.

38.

Filardo

, Kon

, Pereira Ruiz

, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single-versus double-spinning approach. Knee Surgery, Sports Traumatology, Arthroscopy. 2012; 20: 2082-91.

39.

Lastlett

, Young

, Aprill

, et al. Diagnosing painful sacroiliac joints: A validity study of a McKenzie evaluation and sacroiliac provocation tests. The Australian Journal of Physiotherapy. 2003; 49: 89-97.

40.

Lastlett

, Aprill

, McDonald

, et al. Diagnosis of sacroiliac joint pain: Validity of individual provocation tests and composites of tests. Manual Therapy. 2005; 10: 207-18.

41.

Dreyfuss

, Michaelsen

, Pauza

, et al. The value of medical history and physical examination in diagnosing sacroiliac joint pain. Spine. 1996; 21: 2594-602.

42.

Reinert

, Treede

, Bromm

. The pain inhibiting pain effect: An electrophysiological study in humans. Brain Research. 2000; 862: 103-10.